AnaptysBio (NASDAQ: ANAB) awards 16,667 performance stock units to its CMO
Rhea-AI Filing Summary
Lizzul Paul F. reported acquisition or exercise transactions in this Form 4 filing.
ANAPTYSBIO, INC reported that Chief Medical Officer Paul F. Lizzul received a grant of 16,667 Performance Stock Units on March 12, 2026. These performance-based units were earned after achievement of certified criteria, each representing a right to one share of common stock. The award vests 50% on March 12, 2027 and 50% on March 12, 2028, subject to his continued service, leaving him with 16,667 PSUs held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Lizzul Paul F.
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Stock Units F1, F2, F3 | 16,667 | $0.00 | $0.00 |
Holdings After Transaction:
Performance Stock Units — 16,667 shares (Direct)
Footnotes (3)
- F1. Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on March 12, 2026.
- F2. Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.
- F3. The PSUs vest and settle over two years; 50% vests on March 12, 2027 and 50% vests on March 12, 2028, subject to the continuing service of the Reporting Person on each vesting date.
Key Figures
Performance stock units granted: 16,667
Underlying common shares: 16,667
Transaction price per PSU: 0.0000
+2 more
5 metrics
Performance stock units granted
16,667
PSUs earned by Chief Medical Officer Paul F. Lizzul on March 12, 2026
Underlying common shares
16,667
Each PSU represents a conditional right to receive one share of common stock
Transaction price per PSU
0.0000
Reported transaction price per performance stock unit
Vesting on March 12, 2027
50%
First half of the PSUs vest and settle on March 12, 2027
Vesting on March 12, 2028
50%
Second half of the PSUs vest and settle on March 12, 2028
Key Terms
Performance Stock Units, performance-based restricted stock units, conditional right, vest and settle
4 terms
Performance Stock Units financial
"Security title: Performance Stock Units granted to the officer"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
performance-based restricted stock units financial
"Represents performance-based restricted stock units that were earned by the Reporting Person"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
conditional right financial
"Each PSU represents a conditional right to receive one share of the Issuer's Common Stock"
vest and settle financial
"The PSUs vest and settle over two years; 50% vests in 2027 and 50% in 2028"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did ANAPTYSBIO (ANAB) report about Chief Medical Officer Paul F. Lizzul in this Form 4?
ANAPTYSBIO reported that Chief Medical Officer Paul F. Lizzul received a grant of 16,667 performance stock units. These PSUs were earned based on certified performance criteria and will convert into common shares as they vest over 2027 and 2028, subject to his continued service.
How many performance stock units were granted to ANAB's CMO, and what do they represent?
The Chief Medical Officer received 16,667 performance stock units. Each unit represents a conditional right to receive one share of ANAPTYSBIO common stock, so the award can result in 16,667 shares if all units ultimately vest under the plan terms.
When do Paul F. Lizzul's ANAB performance stock units vest?
The performance stock units vest and settle over two years. According to the award terms, 50% vest on March 12, 2027 and the remaining 50% vest on March 12, 2028, provided he continues serving the company on each vesting date.
Were ANAB's performance stock units to the CMO contingent on performance goals?
Yes. The company states that the performance stock units were earned upon achievement of specified performance criteria. Those results were certified by the Compensation Committee of ANAPTYSBIO's Board of Directors on March 12, 2026, triggering the grant of 16,667 units to the CMO.
What is Paul F. Lizzul's reported holding after this ANAB equity grant?
Following the grant, Paul F. Lizzul is reported to hold 16,667 performance stock units directly. These units are derivatives linked to ANAPTYSBIO common stock and will only convert into shares as they vest on the scheduled dates in 2027 and 2028.